MPV17 and myelodysplastic syndrome: We therefore investigated whether the beneficial molecules identified in MPV17-related MDS, capable of increasing dNTPs levels in the sym1∆ strain, were also able to reduce the mtDNA instability of the mip1G651S mutant strain.